• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质包被和多糖包被的脂质体作为药物载体。

Protein-coated and polysaccharide-coated liposomes as drug carriers.

作者信息

Sunamoto J, Iwamoto K

出版信息

Crit Rev Ther Drug Carrier Syst. 1986;2(2):117-36.

PMID:3518958
Abstract

Saccharides on the surface of cell membranes play an important role in cell-cell recognition, which is the most important process utilizable for targeting of drugs encapsulated in an artificial cell, liposome. To design a targetable drug carrier, hence, employing synthesized or natural glycolipids as the recognition site of the liposomal drug carrier is certainly one of useful approach. On the other hand, coating the outermost surface of liposomes with polysaccharide derivatives is also another way for liposomes to be utilized as a targetable drug carrier. In this review, from such a viewpoint, the importance and usefulness of saccharide moiety on the surface of liposomes will be discussed in conjunction with the targeting of drugs.

摘要

细胞膜表面的糖类在细胞间识别中发挥着重要作用,而细胞间识别是将包裹在人工细胞(脂质体)中的药物靶向输送的最重要过程。因此,为了设计一种可靶向的药物载体,采用合成或天然糖脂作为脂质体药物载体的识别位点无疑是一种有用的方法。另一方面,用多糖衍生物包覆脂质体的最外层表面也是将脂质体用作可靶向药物载体的另一种方式。在这篇综述中,将从这样的观点出发,结合药物靶向性来讨论脂质体表面糖部分的重要性和实用性。

相似文献

1
Protein-coated and polysaccharide-coated liposomes as drug carriers.蛋白质包被和多糖包被的脂质体作为药物载体。
Crit Rev Ther Drug Carrier Syst. 1986;2(2):117-36.
2
New polymeric and oligomeric matrices as drug carriers.新型聚合物和低聚物基质作为药物载体。
Crit Rev Ther Drug Carrier Syst. 1986;2(2):175-244.
3
Utility of liposomes coated with polysaccharide bearing 1-amino-lactose as targeting chemotherapy for AH66 hepatoma cells.携带1-氨基乳糖的多糖包被脂质体作为AH66肝癌细胞靶向化疗的效用。
Oncol Rep. 2000 Jan-Feb;7(1):107-11.
4
Pharmaceutical approaches to colon targeted drug delivery systems.结肠靶向给药系统的药物学方法。
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66.
5
Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.亲脂性药物在脂质体膜与生物界面之间的转移:对药物递送的影响。
Eur J Pharm Sci. 2005 Nov;26(3-4):251-65. doi: 10.1016/j.ejps.2005.05.012.
6
Liposomes as targetable drug carriers.
Crit Rev Ther Drug Carrier Syst. 1985;2(1):65-115.
7
Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization.多糖锚定脂质体在药物递送、靶向和免疫方面的潜力。
J Pharm Pharm Sci. 2001 May-Aug;4(2):138-58.
8
Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.聚乙二醇包被的阳离子脂质体包裹的奥沙利铂,通过双靶向方法在小鼠实体瘤模型中显著抑制肿瘤生长。
J Control Release. 2009 Jul 1;137(1):8-14. doi: 10.1016/j.jconrel.2009.02.023. Epub 2009 Mar 12.
9
Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.新型O-棕榈酰硬葡聚糖包被脂质体作为药物载体:研发、表征及其与亮丙瑞林的相互作用
Int J Pharm. 2006 Nov 15;325(1-2):155-62. doi: 10.1016/j.ijpharm.2006.06.040. Epub 2006 Jul 1.
10
The liposomal formulation of doxorubicin.阿霉素的脂质体制剂。
Methods Enzymol. 2005;391:71-97. doi: 10.1016/S0076-6879(05)91004-5.

引用本文的文献

1
Liposomes: structure, composition, types, and clinical applications.脂质体:结构、组成、类型及临床应用。
Heliyon. 2022 May 13;8(5):e09394. doi: 10.1016/j.heliyon.2022.e09394. eCollection 2022 May.
2
Influence of spacer length on interaction of mannosylated liposomes with human phagocytic cells.间隔长度对甘露糖基化脂质体与人类吞噬细胞相互作用的影响。
Pharm Res. 2003 Jan;20(1):51-7. doi: 10.1023/a:1022294624256.